To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
Clinical trial NCT04550949 · UNKNOWN
Trial details
- NCT number
- NCT04550949
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2021-03-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.